Stay updated on Nivolumab Plus Bevacizumab in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.

Latest updates to the Nivolumab Plus Bevacizumab in GBM Clinical Trial page
- Check4 days agoChange DetectedThe page shows minor updates to Study Record Dates and timestamps, with no changes to core trial design, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check32 days agoChange DetectedMajor updates: a government funding status notice and a new version tag (v3.2.0) replace the old version (v3.0.2), signaling updated operating status and software/version information.SummaryDifference2%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with a list of relevant publications from PubMed, while several specific terms related to previous content have been removed.SummaryDifference3%

- Check83 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Bevacizumab in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.